Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06605469 · ClinicalTrials.gov registry record

Ejaculatory and Orgasmic Dysfunction Registry

A clinical trial of Ejaculatory Dysfunction and Premature Ejaculation, sponsored by Charitable Union for the Research and Education of Peyronie's Disease.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT06605469: Recruiting study of Ejaculatory Dysfunction and Premature Ejaculation, sponsored by Charitable Union for the Research and Education of Peyronie's Disease.

NCT06605469 is a study of Ejaculatory Dysfunction and Premature Ejaculation that is actively recruiting participants, run by Charitable Union for the Research and Education of Peyronie's Disease. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06605469, a study of Ejaculatory Dysfunction and Premature Ejaculation, is actively recruiting participants, sponsored by Charitable Union for the Research and Education of Peyronie's Disease.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to evaluate the safety and efficacy of various therapies used to treat ejaculatory and/or orgasmic dysfunctions in men. The objective is to create a large, national registry designed to capture key outcomes for men being treated for ejaculatory and/or orgasmic dysfunction. Participants will submit questionnaires about their diagnosis and treatment efficacy and multiple time intervals.

Study Locations (1)

Utah

  • The Male Fertility and Peyronie's Clinic - Orem

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2024-05-30
Est. Completion 2029-05-31

What the Registry Record Tells You About NCT06605469

The ClinicalTrials.gov registry entry for NCT06605469 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Charitable Union for the Research and Education of Peyronie's Disease, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Ejaculatory Dysfunction appearing as the primary indexed condition, and to 0 interventions.

NCT06605469 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT06605469 about?

NCT06605469 is a clinical study titled "Ejaculatory and Orgasmic Dysfunction Registry". The goal of this observational study is to evaluate the safety and efficacy of various therapies used to treat ejaculatory and/or orgasmic dysfunctions in men. The objective is to create a large, national registry designed to capture key outcomes for men being treated for ejaculatory and/or orgasmic...

What is the current status of trial NCT06605469?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-05-30. Estimated completion is 2029-05-31.

What conditions does trial NCT06605469 study?

This clinical trial studies the following conditions: Ejaculatory Dysfunction, Premature Ejaculation, Delayed Ejaculation, Anorgasmia, Anejaculation.

Who is sponsoring clinical trial NCT06605469?

This trial is sponsored by Charitable Union for the Research and Education of Peyronie's Disease, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06605469 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ejaculatory Dysfunction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.